We are very happy to announce that Professor Roland Andersson from Lund University will join the ApoGlyx Board of Directors!
He has served on the board of numerous biotech companies, most recently in the role of Chairman at Reccan Diagnostics. He adds vast combined academic and entrepreneurial experience to the board, especially in the fields of abdominal infections, inflammation, sepsis and gastrointestinal oncology.
We expect that the addition of Professor Andersson to the Board of Directors will significantly strengthen the strategic development of ApoGlyx.
BACK